[1] Firth AM, Haldane SL.Development of a scale to evaluate postoperative pain in dogs[J]. J Am Vet Med Assoc, 1999,214:651-659. [2] Holton LL, Scott EM, Nolan AM,et al.Comparison of three methods used for assessment of pain in dogs[J]. J Am Vet Med Assoc, 1998, 212(1):61-66. [3] 孙振球, 徐勇勇. 医学统计学[M]. 北京: 人民卫生出版社.2006.587-596. [4] 江鹏亮, 袁卫. 犬胫骨骨折模型的建立[J]. 上海实验动物科学, 2004, 24(2):103-104. [5] 祝云利, 荆鑫, 缪志和, 等. 纤维软骨细胞-胶原复合物修复半月板损伤的实验研究[J]. 解放军医学杂志, 2002, 27(1):20-21. [6] Talley J.N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration[J]. J Med Chem, 2000, 43,1661-1663. [7] Hubbard RC, Naumann TM, Traylor L, et al.Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia[J]. Br J Anaesth, 2003, 90(2):166-172. [8] Jirarattanaphochai K, Thienthong S, Sriraj W.Effect of parecoxib on postoperative pain after lumbar spine surgery[J]. Spine,2008, 33( 2):132-139. [9] Kiefer W, Dannhardt G.Novel insights and therapeutical applications in the field of inhibitors of COX-2[J]. Curr Med Chem, 2004, 11(24):3147-61. [10] Sinatra R.Role of COX-2 inhibitors in the evolution of acute pain management[J]. J Pain Symptom Manage, 2002, 24(1 Suppl):S18-27. [11] Dannhardt G, Kiefer W.Cyclooxygenase inhibitors-current status and future prospects[J]. Eur J Med Chem, 2001, 36:109-126. [12] Hinz B, Brune K.Cyclooxygenase-2-10 years later[J]. J Pharmacol Exp Ther, 2002, 300:367-375. [13] Buvanendran A, Kroin JS.Multimodal analgesia for controlling acute postoperative pain[J]. J Curr Opin Anaesthesiol, 2009, 22(5):588-593. |